Related Experiment Video
Updated: Nov 26, 2025

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
When Should We Let Colorectal Cancer Screening Get Personal?
Angela Y Lam1, Jeffrey K Lee1,2
1Department of Gastroenterology, Kaiser Permanente San Francisco, San Francisco, California, USA.
Improving colorectal cancer (CRC) screening requires more than just risk assessment. Combining risk estimation with patient navigation and decision support tools may enhance screening uptake for this common cancer.
Area of Science:
- Oncology
- Preventive Medicine
- Public Health
Background:
- Colorectal cancer (CRC) screening significantly reduces incidence and mortality.
- Suboptimal national CRC screening rates necessitate improved intervention strategies.
- Perceived CRC risk correlates with screening likelihood, but risk assessment alone is insufficient.
Purpose of the Study:
- To evaluate the effectiveness of risk estimation tools in improving CRC screening uptake.
- To identify additional components that can enhance CRC screening interventions.
Main Methods:
- Utilized the National Cancer Institute Colorectal Cancer Risk Assessment Tool for risk estimation.
- Compared screening uptake between risk assessment education and general education.
Main Results:
- Risk estimation alone, using the validated tool, did not improve CRC screening uptake compared to general education.
- Existing literature suggests a link between perceived CRC risk and screening intent.
Conclusions:
- Risk estimation tools, when used in isolation, are insufficient to increase CRC screening rates.
- Future interventions should integrate risk estimation with patient navigation and decision support aids for improved effectiveness.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Prevention
Some...